Business Context and Reporting Period
This Form 6-K filing by Check-Cap Ltd. (referred to as Mbody AI Ltd. in metadata) covers the period of October 9, 2018. The registrant is a foreign private issuer based in Israel. The filing serves to disclose a material corporate event rather than providing periodic financial results.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is an informational disclosure regarding a regulatory submission and does not contain financial statements or performance metrics.
Material Changes
The primary material event disclosed is the Company's submission of an Investigational Device Exemption (IDE) application to the U.S. Food and Drug Administration (FDA) for its C-Scan® system. This submission was announced via a press release dated October 9, 2018.
Guidance, Outlook, and Risks
Management commentary is limited to the announcement of the FDA IDE submission. The filing does not contain specific financial guidance, future outlook projections, or a detailed discussion of risks and contingencies beyond the context of the regulatory filing. No unusual items were reported in this specific document.
Investor Verification Checklist
- Verify the status and outcome of the C-Scan® system IDE submission with the FDA.
- Review the attached press release (Exhibit 99.1) for specific details on the C-Scan® technology and trial design.
- Confirm the Company's current financial position through its most recent Form 20-F or quarterly reports, as this 6-K contains no financial data.
- Monitor for subsequent updates regarding the FDA review timeline and any potential clinical trial milestones.